- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05993260
Using Text Messages to Boost COVID-19 Vaccine Booking Rate
Using Text Messages to Boost COVID-19 Vaccination Appointment Booking and Vaccination Rates: A Randomised Controlled Field Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, SE1 8UG
- NHS England
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- (i) satisfying the age criteria as defined above;
- (ii) recorded in the National Immunisation Management System (NIMS);
- (iii) with a valid mobile phone number;
- (iv) who had not already received or been invited for the COVID-19 vaccine via NIMS at the time of the study.
Exclusion Criteria:
- Participants with invalid phone numbers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
Received the text message "You are now eligible for your free NHS Covid-19 vaccine.
Please book yours now at [LINK] or by calling 119."
|
Control vaccination eligibility reminder text message
|
Experimental: Simple
Received the text message "You can now book your free NHS Covid-19 vaccine.
Please book yours now at [LINK] or by calling 119."
|
Behaviourally-informed content in vaccination eligibility reminder text messages
|
Experimental: Reserved
Received the text message "Your free NHS Covid-19 vaccine is waiting for you.
Please book yours now at [LINK] or by calling 119."
|
Behaviourally-informed content in vaccination eligibility reminder text messages
|
Experimental: Top of queue
Received the text message "You've reached the top of the queue and are a priority for getting a free NHS Covid-19 vaccine.
Please book yours now at [LINK] or by calling 119."
|
Behaviourally-informed content in vaccination eligibility reminder text messages
|
Experimental: Join the millions
Received the text message "You are now eligible for your free NHS Covid-19 vaccine.
Join the millions who have already had theirs.
Please book yours now at [LINK] or by calling 119."
|
Behaviourally-informed content in vaccination eligibility reminder text messages
|
Experimental: Convenience
Received the text message "You are now eligible for your free NHS Covid-19 vaccine.
Choose a time and place that suits you.
Please book yours now at [LINK] or by calling 119."
|
Behaviourally-informed content in vaccination eligibility reminder text messages
|
Experimental: Protection against virus
Received the text message "You are now eligible for your free NHS Covid-19 vaccine.
Getting vaccinated is the best protection against coronavirus.
Please book yours now at [LINK] or by calling 119."
|
Behaviourally-informed content in vaccination eligibility reminder text messages
|
Experimental: Protect you and those close to you
Received the text message "You are now eligible for your free NHS Covid-19 vaccine.
Getting the vaccine is the best way to protect yourself and those close to you against coronavirus.
Please book yours now at [LINK] or by calling 119."
|
Behaviourally-informed content in vaccination eligibility reminder text messages
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Booking rate within 72 hours
Time Frame: 72 hours
|
The proportion of first dose vaccination appointments booked through the NHS National Booking System within 72 hours (inclusive) of the text message being sent
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vaccination rate within 14 days
Time Frame: 14 days
|
The proportion of first dose vaccinations received within 14 days (inclusive) of the text message being sent
|
14 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Hannah Behrendt, PhD, The Behavioural Insights Team
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021035
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All data requests should be submitted to NHS England and NHS Improvement (the data controller) for consideration. Access to the raw anonymised data may be granted for non-commercial research at the discretion of NHS England and NHS Improvement. Further information can be obtained from the corresponding author at hannah.behrendt@bi.team.
Custom code that supports the findings of this study is available from the corresponding author upon request.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
Massachusetts General HospitalRecruitingPost Acute COVID-19 Syndrome | Long COVID | Post Acute Sequelae of COVID-19 | Long COVID-19United States
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 Vaccines | COVID-19 Virus DiseaseIndonesia
-
University of Witten/HerdeckeInstitut für Rehabilitationsforschung NorderneyCompletedPost-COVID-19 Syndrome | Long-COVID-19 SyndromeGermany
-
Jonathann Kuo, MDActive, not recruitingSARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditionsUnited States
-
University Hospital, Ioannina1st Division of Internal Medicine, University Hospital of IoanninaRecruitingCOVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Pandemic | COVID-19 Acute Respiratory Distress Syndrome | COVID-19-Associated Pneumonia | COVID 19 Associated Coagulopathy | COVID-19 (Coronavirus Disease 2019) | COVID-19-Associated ThromboembolismGreece
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted